📊 Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
15
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
34%
💰 Capital Raise
55%
• Critical: only 1.6 months cash remaining
🔄 Reverse Split
15%
• Only 2 months cash — financial pressure
📉 Score Deterioration
10%
• Score in HIGH risk zone (65/100)
💹 Market Data
Market Cap$20.74M
Shares Outstanding8.33M
Float6.88M
Cash$1.12M
Debt$11.46M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 38.2% shares (2025Q4 vs prior)
29 institutional holders · 16.14M shares
#1
Lagoda Investment Management, L.P.
11.46M shares
#2
VANGUARD GROUP INC
1.53M shares
#3
GEODE CAPITAL MANAGEMENT, LLC
964.0K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest269.1K
Days to Cover1.4
% of Float3.9%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Mar 31, 2026
4
INSIDER TRANSACTION
Mar 19, 2026
4
INSIDER TRANSACTION
Mar 19, 2026
4
INSIDER TRANSACTION
Mar 19, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for VNRX
📊 VNRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 VNRX Signal Convergence & Dark Pool Activity — StonkWhisper
📄 VNRX Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.